Get the Stockscreener App
22.52
2.04%
0.45
After Hours:
22.52
Phibro Animal Health Corp stock is traded at $22.52, with a volume of 338.65K.
It is up +2.04% in the last 24 hours and up +7.24% over the past month.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
See More
Previous Close:
$22.07
Open:
$22.05
24h Volume:
338.65K
Relative Volume:
2.03
Market Cap:
$920.24M
Revenue:
$982.01M
Net Income/Loss:
$14.80M
P/E Ratio:
27.46
EPS:
0.82
Net Cash Flow:
$37.02M
1W Performance:
+2.41%
1M Performance:
+7.24%
6M Performance:
+74.17%
1Y Performance:
+76.35%
1-Day Range:
$21.93
$22.84
1-Week Range:
$21.80
$22.84
52-Week Range:
$9.40
$22.84
Phibro Animal Health Corp Stock (PAHC) Company Profile
Name
Phibro Animal Health Corp
Sector
Phone
201-329-7300
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-21-22 | Initiated | ROTH Capital | Buy |
| Jul-25-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-10-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Nov-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-07-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Aug-06-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-06-20 | Downgrade | Gabelli & Co | Buy → Hold |
| Jan-28-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Sep-05-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Aug-29-19 | Reiterated | BofA/Merrill | Underperform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| May-23-19 | Initiated | Guggenheim | Neutral |
| May-09-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-23-17 | Resumed | BofA/Merrill | Underperform |
| Jun-02-17 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-15-16 | Initiated | Piper Jaffray | Overweight |
| Nov-11-16 | Downgrade | Macquarie | Neutral → Underperform |
| Nov-10-16 | Downgrade | Gabelli & Co | Buy → Hold |
| Apr-11-16 | Reiterated | Guggenheim | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Jan-15-16 | Downgrade | Barclays | Overweight → Underweight |
| Sep-30-15 | Initiated | Gabelli & Co | Buy |
| Apr-24-15 | Reiterated | Barclays | Overweight |
| Apr-21-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-06-14 | Initiated | Barclays | Overweight |
View All
Phibro Animal Health Corp Stock (PAHC) Latest News
Phibro (PAHC) Up 2.9% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance
Zacks Industry Outlook Highlights Boston Scientific, Baxter International, Haemonetics and Phibro Animal Health - Yahoo Finance
American Century Companies Inc. Grows Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - MarketBeat
Pitney Bowes’ Former E-Comm Segment Lays Off 1,200 in Liquidation - Sourcing Journal
PhilHealth approves Aklan Health Care Provider Network - Daily Guardian
Himadri Speciality Chemical announces cessation of director - Business Standard
Take the Zacks Approach to Beat the Markets: Phibro Animal Health, Travelzoo, Ollie's Bargain Outlet in Focus - Yahoo Finance
Phividec probes firm with alleged links to POGO - pna.gov.ph
UAE Veterinary Medicine Market, By Region, Competition, Forecast and Opportunities, 2029F - GlobeNewswire Inc.
1st Phorm Andy Frisella : 1st Phorm Founder Faces Backlash Over Sexist Remarks Against Female Police Officers - CGNEWS24
1st Phorm Andy Frisella : 1st Phorm CEO Distances Himself from Brother Controversial Comments - CGNEWS24
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio - Yahoo Finance Australia
HABI: The Philippine Textile Council is weaving the future — Events - Asian Journal News
Phibro Anim stock soars to 52-week high, hits $22.31 By Investing.com - Investing.com Australia
Phibro Anim stock soars to 52-week high, hits $22.31 - Investing.com
Phibro Animal Health (NASDAQ:PAHC) Sets New 12-Month High at $22.55 - MarketBeat
Is Phibro Stock Worth Retaining in Your Portfolio Now? - Yahoo Finance
Phibro Anim stock soars to 52-week high, hits $22.31 By Investing.com - Investing.com UK
Animal Feed Minerals Market Set to Grow at 3.9% CAGR from 2024 to 2034, Reaching USD 6.1 Billion | Future Market Insights, Inc. - GlobeNewswire Inc.
Q1 2025 Earnings Forecast for Phibro Animal Health Co. Issued By Zacks Research (NASDAQ:PAHC) - MarketBeat
PAHC Stock Gains From Innovation, Market Expansion Goal - Yahoo Finance
Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by Principal Financial Group Inc. - Defense World
Phibro Animal Health Co. to Post Q1 2025 Earnings of $0.20 Per Share, Zacks Research Forecasts (NASDAQ:PAHC) - Defense World
Phibro Animal Health Co. (NASDAQ:PAHC) Receives $15.00 Consensus PT from Brokerages - Defense World
Phibro Animal Health Co. to Post Q1 2025 Earnings of $0.20 Per Share, Zacks Research Forecasts (NASDAQ:PAHC) - MarketBeat
Phibro Animal Health Corp. [PAHC] Insider Activity: An Update for Investors - Knox Daily
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - MSN
Acadian Asset Management LLC Has $12.03 Million Stock Position in Phibro Animal Health Co. (NASDAQ:PAHC) - MarketBeat
Phibro Animal Health Co. (NASDAQ:PAHC) Given Consensus Recommendation of "Strong Sell" by Brokerages - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Earns Neutral Rating from Analysts at JPMorgan Chase & Co. - MarketBeat
JPMorgan sees upside for Phibro Animal Health stock after recent ZTS acquisition - Investing.com Canada
Animal Antibiotics and Antimicrobials Market Report 2024-2033: Size, Share, Trends, and Outlook - WhaTech
JPMorgan sees upside for Phibro Animal Health stock after recent ZTS acquisition - Investing.com Australia
JPMorgan sees upside for Phibro Animal Health stock after recent ZTS acquisition - Investing.com India
JPMorgan sees upside for Phibro Animal Health stock after recent ZTS acquisition - Investing.com
Phibro Animal Health initiated with a Neutral at JPMorgan - TipRanks
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
Executives Buying BJ's Restaurants And 2 Other Stocks - Benzinga
Independent Non-Executive Director of Phibro Animal Health E. Corcoran Buys 25% More Shares - Simply Wall St
E Thomas Corcoran Purchases 5,000 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) Stock - Defense World
Phibro Animal Health director Corcoran buys $100,100 in stock - Investing.com
Phibro Animal Health director Corcoran buys $100,100 in stock - Investing.com India
E Thomas Corcoran Acquires 5,000 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) Stock - MarketBeat
Director E Corcoran Acquires 5,000 Shares of Phibro Animal Health Corp (PAHC) - Yahoo Finance
Director E Corcoran Acquires 5,000 Shares of Phibro Animal Healt - GuruFocus.com
Director E Corcoran Acquires 5,000 Shares of Phibro Animal Health Corp (PAHC) By GuruFocus - Investing.com Canada
Are You Looking for a Top Momentum Pick? Why Phibro Animal Health (PAHC) is a Great Choice - Yahoo Finance
Implied Volatility Surging for Phibro Animal Health (PAHC) Stock Options - Yahoo Finance
Phibro Animal Health Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Here's Why Phibro Animal Health (PAHC) is a Strong Momentum Stock - Yahoo Finance
Phibro Animal Health Corp Stock (PAHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.23%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):